Rapid clinical assessment of hemodynamic profiles and targeted treatment of patients with acutely decompensated heart failure

Clinical Cardiology

Volumn 27, Issue 9 SUPPL., 2004, Pages

  Fonarow, Gregg C ^a,c,d   Weber, Jim Edward ^b,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UCLA Division of Cardiology   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e HURLEY MEDICAL CENTER   (United States)

Author keywords

Acutely decompensated heart failure; Bedside assessment; Emergency department; Hemodynamic profile; Natriuretic peptide; Vasodilators

Indexed keywords

ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; DOPAMINE; GLYCERYL TRINITRATE; INOTROPIC AGENT; LOOP DIURETIC AGENT; MILRINONE; NESIRITIDE; PLACEBO; VASODILATOR AGENT;

ADULT; AGED; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; FEMALE; HEART ARRHYTHMIA; HEART CATHETERIZATION; HEART FAILURE; HEART OUTPUT; HEMODYNAMIC MONITORING; HUMAN; INOTROPISM; LUNG CONGESTION; MAJOR CLINICAL STUDY; MALE; NATRIURESIS; REVIEW; RISK ASSESSMENT; SURVIVAL;

EID: 4344677909     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, Graniats TG, Goldstein S, Gregoratos G, Jessup ML, Noble RJ, Packer M, Silver MA, Stevenson LW: ACC/AHA guidelines forthe evaluation and management of chronic heart failure in the adult: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). 2001. American College of Cardiology website. Available at: http://www.acc.org/clinical/guidelines/failure/hf_index.htm
2. 2003 Heart and Stroke Statistical Update. Dallas, Tex.: American Heart Association, 2002
3. Nohria A, Lewis E, Stevenson LW: Medical management of advanced heart failure. J Am Med Assoc 2002;287:628-640
4. Cody R: Clinical trials of diuretic therapy in heart failure: Research directions and clinical considerations. J Am Coll Cardiol 1993;22(4 suppl A):165A-171A
5. Fonarow GC: The treatment targets in acute decompensated heart failure. Rev Cardiovasc Med 2001;2:7-12
6. Gandhi SK, Powers JC, Nomier AM, Fowle K, Kitzman DW, Rankin KM, Little WC: The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med 2001;344:17-22
7. Fonarow GC, Hamilton MA, Moriguchi J, Creaser JW, Rourke DA: Hemodynamic predictors of clinical outcomes in decompensated advanced heart failure. J Cardiac Fail 2001;7(suppl 2):038
8. Stevenson LW, Tillisch JH, Hamilton M, Luu M, Chelimsky-Fallick C, Moriguchi J, Kobashigawa J, Walden J: Importance of hemodynamic response to therapy in predicting survival with ejection fraction less than or equal to 20% secondary to ischemic or nonischemic dilated cardiomyopathy. Am J Cardiol 1990;66:1348-1354
9. Natriuretic Peptides in Health and Disease (Eds. Samson WK, Levin ER). Totowa, N.J.: Humana Press, 1997
10. Cheng V, Kazanagra R, Garcia A, Lenert L, Krishnaswamy P, Gardetto N, Clopton P, Maisel A: A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: A pilot study. J Am Coll Cardiol 2001; 37:386-391
11. Forrester JS, Diamond G, Chatterjee K, Swan HJ: Medical therapy of acute myocardial infarction by application of hemodynamic sub-sets (second of two parts). N Engl J Med 1976;295:1404-1413
12. Nohria A, Tsang SW, Fang JC, Lewis EF, Jarcho JA, Mudge GH, Stevenson LW: Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol 2003;41:1797-1804
13. Dries DL, Exner DV, Domanski MJ, Greenberg B, Stevenson LW: The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with ventricular systolic dysfunction. J Am Coll Cardiol 2000;35:681-689
14. Hillege HL, Girbes AR, de Kam PJ, Boomsma F, de Zeeuw D, Charlesworth A, Hampton JR, van Veldhuisen DJ: Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 2000;102:203-210
15. Weinfeld MS, Chertow GM, Stevenson LW: Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure. Am Heart J 1999;138(2 Pt. 1):285-290
16. Gottlieb SS, Abraham W, Butler J, Forman DE, Loh E, Massie BM, O'Connor CM, Rich MW, Stevenson LW, Young J, Krumholz HM: The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Cardiol Fail 2002;8:136-141
17. Kubo SH, Clark M, Laragh JH, Borer JS, Cody RJ: Identification of normal neurohormonal activity in mild congestive heart failure and stimulating effect of upright posture and diuretics. Am J Cardiol 1987;60:1322-1328
18. Cotter G, Metzkor E, Kaluski E, Faigenberg Z, Miller R, Simovitz A, Shaham O, Marghitay D, Koren M, Blatt A, Moshkovitz Y, Zaidenstein R, Golik A: Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary edema. Lancet 1998;351:389-393
19. Gottlieb SS, Brater DC, Thomas I, Havranek E, Bourge R, Goldman S, Dyer F, Gomez M, Bennett D, Ticho B, Beckman E, Abraham W: BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Circulation 2002;105:1348-1353
20. Ewy GA: Inotropic infusions for chronic congestive heart failure: Medical miracles or misguided medicinals? J Am Coll Cardiol 1999;33:572-575
21. Cuffe MS, Califf RM, Adams KF Jr, Benza R, Bourge R, Colucci WS, Massie BM, O'Connor CM, Pina I, Quigg R, Silver MA, Gheorghiade M: Short-term intravenous milrinone for acute exacerbation of chronic heart failure. J Am Med Assoc 2002;287:1541-1547
22. Fonarow GC, Chelimsky-Fallick C, Stevenson LW, Luu M, Hamilton MA, Moriguchi JD, Tillisch JH, Walden JA, Albanese E: Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: The Hy-C trial. J Am Coll Cardiol 1992;19: 842-850
23. Steimle AE, Stevenson LW, Chelimsky-Fallick C, Fonarow GC, Hamilton MA, Moriguchi JD, Kartashov A, Tillisch JH: Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure. Circulation 1997; 96:1165-1172
24. Fonarow GC, Stevenson LW, Walden JA, Livingston NA, Steimle AE, Hamilton MA, Moriguchi J, Tillisch JH, Woo MA: Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure. J Am Coll Cardiol 1997;30:725-732
25. Koller-Strametz J, Wolzt M, Fuchs C, Putz D, Wisser W, Mensik C, Eichler HG, Laufer G, Schmetterer L: Renal hemodynamic effects of L-arginine and sodium nitroprusside in heart transplant recipients. Kidney Int 1999;55:1871-1877
26. VMAC Investigators: Intravenous nesiritide vs. nitroglycerin for treatment of decompensated congestive heart failure. J Am Med Assoc 2002;287:1531-1540
27. Elkayam U, Johnson JV, Shotan A, Bokhari S, Solodky A, Canetti M, Wani OR, Karaalp IS: Double-blind, placebo-controlled study to evaluate the effect of organic nitrates in patients with chronic heart failure treated with angiotensin-converting enzyme inhibition. Circulation 1999;99:2652-2657
28. Levin ER, Gardner DG, Samson WK: Natriuretic peptides. N Engl J Med 1998;339:321-328
29. Michaels AD, Klein A, Madden JA, Chatterjee K: Effects of intravenous nesiritide on human coronary vasomotor regulation and myocardial oxygen uptake. Circulation 2003;107:2697-2701
30. Colucci WS, Elkayam U, Horton DP, Abraham WT, Bourge RC, Johnson AD, Wagoner LE, Givertz MM, Liang CS, Neibaur M, Haught WH, LeJemtel TH, for the Nesiritide Study Group: Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. N Engl J Med 2000;343:246-253
31. Burger AJ, Elkayam U, Neibaur MT, Haught H, Ghali J, Horton DP, Aronson D: Comparison of the occurrence of ventricular arrhythmias in patients with acutely decompensated congestive heart failure receiving dobutamine versus nesiritide therapy. Am J Cardiol 2001;88:35-39
32. Burger AJ, Horton DP, LeJemtel T, Ghali JK, Torre G, Dennish G, Koren M, Dinerman J, Silver M, Cheng ML, Elkayam U: Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: The PRECEDENT study. Am Heart J 2002;144:1102-1108
33. Peacock F, Emerman CL, Costanzo MR, Berkowitz RL, Cheng M: Early initiation of intravenous vasoactive therapy improves heart failure outcomes: An analysis from The ADHERE Registry database. Ann Emerg Med 2003;42(4):S26